Peptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results

Michael Garkavij; Mattias Nickel; Katarina Sjögreen Gleisner; Michael Ljungberg; Sven-Erik Strand; Tomas G Ohlsson; Jan Tennvall

Peptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results

Michael Garkavij, Mattias Nickel, Katarina Sjögreen Gleisner, Michael Ljungberg, Sven-Erik Strand, Tomas G Ohlsson, Jan Tennvall

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

Originalspråk	engelska
Sidor (från-till)	44
Tidskrift	Neuroendocrinology
Volym	90
Nummer	1
Status	Published - 2009
Evenemang	6th Annual Conference of the European-Neuroendocrine-Tumor-Society - Granada, SPAIN Varaktighet: 2009 mars 5 → 2009 mars 7

Ämnesklassifikation (UKÄ)

Cancer och onkologi
Radiologi och bildbehandling

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Citera det här

@article{46a952b218ed4cb3a6768ffd7ef1caf3,

title = "Peptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results",

author = "Michael Garkavij and Mattias Nickel and {Sj{\"o}green Gleisner}, Katarina and Michael Ljungberg and Sven-Erik Strand and Ohlsson, {Tomas G} and Jan Tennvall",

year = "2009",

language = "English",

volume = "90",

pages = "44",

journal = "Neuroendocrinology",

issn = "0028-3835",

publisher = "Karger",

number = "1",

note = "6th Annual Conference of the European-Neuroendocrine-Tumor-Society ; Conference date: 05-03-2009 Through 07-03-2009",

}

TY - JOUR

T1 - Peptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results

AU - Garkavij, Michael

AU - Nickel, Mattias

AU - Sjögreen Gleisner, Katarina

AU - Ljungberg, Michael

AU - Strand, Sven-Erik

AU - Ohlsson, Tomas G

AU - Tennvall, Jan

PY - 2009

Y1 - 2009

M3 - Published meeting abstract

SN - 0028-3835

VL - 90

SP - 44

JO - Neuroendocrinology

JF - Neuroendocrinology

IS - 1

T2 - 6th Annual Conference of the European-Neuroendocrine-Tumor-Society

Y2 - 5 March 2009 through 7 March 2009

ER -